Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2020-12-16 Capital/Financing Update
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Appendix 2A 9 pages 206.4KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, and the purpose of the issue. This type of document is a regulatory announcement related to capital markets activity, specifically the issuance and quotation of new securities. It is not a financial report, earnings release, or management discussion. It is also not a proxy, voting result, or governance document. The document is a formal regulatory filing to the exchange about capital changes, specifically new securities issuance and quotation. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive regulatory filing about capital changes.
2020-12-16 English
Appendix 2A - options exercise & cleansing notice 11 pages 418.0KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, and specifics about the securities issuance such as options exercised or convertible securities converted. This type of document is a regulatory announcement related to capital markets activity, specifically the listing or quotation of new securities. It is not a financial report, earnings release, or management discussion. It is also not a proxy, AGM material, or voting results announcement. The document is a formal regulatory filing to the exchange about securities quotation, which fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the securities issuance, not just a brief announcement or a report publication notice. Therefore, the best classification is Capital/Financing Update (CAP).
2020-12-16 English
Change of Director's interest notice x 4 9 pages 399.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings and interests of multiple company directors, including the number of shares and rights acquired or disposed, dates of changes, and nature of interests. The document is a formal notification of personal share transactions by company directors. There is no financial performance data, earnings information, or report publication content. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is substantial and contains detailed transaction data, confirming it is the report itself, not an announcement or certification. Therefore, the correct classification is DIRS.
2020-12-16 English
TGA announces final CBD down-scheduling decision 3 pages 483.0KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 16 December 2020 from Little Green Pharma regarding the Therapeutic Goods Administration (TGA) final decision to down-schedule cannabidiol (CBD) products and increase the maximum daily dose. It discusses regulatory changes, industry impact, and company commentary. There are no financial statements, earnings data, or detailed financial analysis present. The document is an update on regulatory and industry developments rather than a financial report or management discussion. It is not a report publication announcement since it does not mention the release or availability of a report. It is also not a call transcript, AGM material, or any other specific financial filing. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about changes affecting the company and its industry.
2020-12-15 English
Company Update to the AGM 16 pages 1.6MB
AGM Information Classification · 95% confidence The document is titled 'AGM COMPANY UPDATE' and is dated 26 November 2020, coinciding with the company's Annual General Meeting (AGM). It contains a Managing Director's Company Update presentation provided in advance of the AGM. The content includes corporate overview, business model, growth strategy, patient access, manufacturing capabilities, sales and distribution, and news flow, all typical of materials presented at an AGM. There is no indication that this is a full annual report or financial statements, nor is it a voting results announcement or proxy solicitation. The document is a presentation given at the AGM, matching the description of 'Presentations and materials shared during the Annual General Meeting (AGM).' Therefore, the appropriate classification is AGM Information (AGM-R). The document length (over 14,000 characters) and detailed content support this classification with high confidence.
2020-11-25 English
Results of Annual General Meeting 2 pages 228.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF ANNUAL GENERAL MEETING' and provides detailed voting results for resolutions passed at the AGM held on 26 November 2020. It includes proxy and poll results for multiple resolutions, which is typical for a declaration of voting results. The document does not contain financial statements or detailed report content but focuses on the outcome of shareholder votes. Therefore, it fits the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is short and it is an announcement of voting results, not the AGM materials themselves or the full annual report.
2020-11-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.